NCT07374614
- Conditions
- ALK, Bronchial Neoplasms, Carcinoma, Bronchogenic, +13 more
- Locations
-
- Peking University Shenzhen Hospital Shenzhen, Guangdong, China
Clinical trial condition
Lorlatinib
Explore clinical trials studying Lorlatinib. Study availability and eligibility vary by location and protocol.
1 public trial
1 recruiting study